Vertex Pharmaceuticals Stock Soars As Non-Opioid Pain Treatment Gets FDA Nod
January 31, 2025 at 13:08 PM EST
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain.
